Aclarion, Inc. (ACON)
NASDAQ: ACON · Real-Time Price · USD
0.0423
-0.0027 (-6.00%)
At close: Jan 17, 2025, 4:00 PM
0.0424
+0.0001 (0.24%)
After-hours: Jan 17, 2025, 7:59 PM EST
Aclarion Employees
As of December 31, 2023, Aclarion had 6 total employees, including 4 full-time and 2 part-time employees. The number of employees decreased by 1 or -14.29% compared to the previous year.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
$8,215
Profits / Employee
-$1,046,807
Market Cap
441.56K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 6 | -1 | -14.29% |
| Dec 31, 2022 | 7 | 1 | 16.67% |
| Dec 31, 2021 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
ACON News
- 2 months ago - Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash - GlobeNewsWire
- 2 months ago - Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st - Accesswire
- 3 months ago - Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit - GlobeNewsWire
- 4 months ago - Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes - GlobeNewsWire
- 4 months ago - PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology - GlobeNewsWire
- 4 months ago - Aclarion Provides Corporate Update on Nociscan AI Technology Milestones - GlobeNewsWire
- 4 months ago - Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial - GlobeNewsWire
- 4 months ago - Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market - GlobeNewsWire